{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:17:58Z","timestamp":1793755078445,"version":"4.6.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[1997,1,1]],"date-time":"1997-01-01T00:00:00Z","timestamp":852076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1997,1,1]],"date-time":"1997-01-01T00:00:00Z","timestamp":852076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[1997,1]]},"DOI":"10.1136\/ard.56.1.27","type":"journal-article","created":{"date-parts":[[2008,12,5]],"date-time":"2008-12-05T19:32:33Z","timestamp":1228505553000},"page":"27-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":138,"title":["The timing of glucocorticoid administration in rheumatoid arthritis"],"prefix":"10.1016","volume":"56","author":[{"given":"Nils Gunnar","family":"Arvidson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Gudbj\u00f6rnsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"H\u00e4llgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.56.1.27_bib1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987. Revised criteria for the classification of rheumatoid arthritis.","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.56.1.27_bib2","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1002\/art.1780241012","article-title":"Preliminary criteria for clinical remission in rheumatoid arthritis.","volume":"24","author":"Pinals","year":"1981","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.56.1.27_bib3","first-page":"280","article-title":"Scientific assessment of the results of physical treatment \u2013 measurement of stiffness.","volume":"8","author":"Wright","year":"1966","journal-title":"Ann Phys Med"},{"key":"10.1136\/ard.56.1.27_bib4","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1365-2125.1981.tb01153.x","article-title":"Circadian variations in the signs and symptoms of rheumatoid arthritis and in the therapeutic effectiveness of flurbiprofen at different times of day.","volume":"11","author":"Kowanko","year":"1981","journal-title":"Br J Clin Pharmacol"},{"key":"10.1136\/ard.56.1.27_bib5","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1136\/bmj.284.6315.551","article-title":"Circadian variation in disease activity in rheumatoid arthritis.","volume":"284","author":"Harkness","year":"1982","journal-title":"BMJ"},{"key":"10.1136\/ard.56.1.27_bib6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0025-6196(24)00526-3","article-title":"The effect of a hormone of the adrenal cortex and of pituitary adrenocorticothropic hormone on rheumatoid arthritis.","volume":"24","author":"Hench","year":"1949","journal-title":"Proc Mayo Clin"},{"key":"10.1136\/ard.56.1.27_bib7","doi-asserted-by":"crossref","first-page":"564","DOI":"10.7326\/0003-4819-88-4-564","article-title":"Corticosteroid-induced lymphopenia, immunosuppression and body defence.","volume":"88","author":"Craddock","year":"1978","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.56.1.27_bib8","first-page":"21","article-title":"Mechanisms of anti-inflammatory actions of glucocorticoids.","volume":"2","author":"Fahey","year":"1981","journal-title":"Adv Inflammation Res"},{"key":"10.1136\/ard.56.1.27_bib9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00007890-199001000-00040","article-title":"Evidence that glucocorticoids block expression of the human interleukin-6 gene by accessory cells.","volume":"49","author":"Zanker","year":"1990","journal-title":"Transplantation"},{"key":"10.1136\/ard.56.1.27_bib10","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/art.1780370803","article-title":"Specker C. Effects of glucocorticoids in rheumatoid arthritis.","volume":"37","author":"Schlaghecke","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.56.1.27_bib11","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1136\/ard.53.8.521","article-title":"Circadian rhythm of serum interleukin-6 in rheumatoid arthritis.","volume":"53","author":"Arvidson","year":"1994","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.56.1.27_bib12","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0002-9343(77)90233-9","article-title":"Potency and duration of action of glucocorticoids. Effects of hydrocortisone, prednisolone and dexamethasone on human pituitary-adrenal function.","volume":"63","author":"Meikle","year":"1977","journal-title":"Am J Med"},{"key":"10.1136\/ard.56.1.27_bib13","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1432-1033.1988.tb13997.x","article-title":"Regulation of synthesis and secretion of major rat acute phase proteins by recombinant human interleukin-6 (BSF-2\/IL-6) in hepatocyte primary cultures.","volume":"173","author":"Andus","year":"1988","journal-title":"Eur J Biochem"},{"key":"10.1136\/ard.56.1.27_bib14","doi-asserted-by":"crossref","first-page":"4136","DOI":"10.1016\/S0021-9258(19)39713-3","article-title":"Cis-acting elements responsible for interleukin-6 inducible C-reactive protein expression.","volume":"265","author":"Li","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1136\/ard.56.1.27_bib15","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1042\/bj2650621","article-title":"Interleukin-6 and the acute phase response.","volume":"265","author":"Heinrich","year":"1990","journal-title":"Biochem J"},{"key":"10.1136\/ard.56.1.27_bib16","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.4049\/jimmunol.147.4.1261","article-title":"Effect of combinations of cytokines and hormones on synthesis of serum amyloid A and C-reactive protein in HEP 3 B cells.","volume":"147","author":"Ganpathi","year":"1991","journal-title":"J Immunol"},{"key":"10.1136\/ard.56.1.27_bib17","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.4049\/jimmunol.145.10.3297","article-title":"IL-6 is produced by osteoblasts and induces bone resorption.","volume":"145","author":"Yoshiko","year":"1990","journal-title":"J Immunol"},{"key":"10.1136\/ard.56.1.27_bib18","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1210\/endo.131.5.1425421","article-title":"Evidence for an autocrine\/paracrine role for interleukin-6 in bone resorption by giant cells from giant cell tumours of bone.","volume":"131","author":"Ohsaki","year":"1992","journal-title":"Endocrinology"},{"key":"10.1136\/ard.56.1.27_bib19","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/jbmr.5650070502","article-title":"Interleukin-6: an osteoporotic factor?","volume":"7","author":"Roodman","year":"1992","journal-title":"Bone Miner Res"},{"key":"10.1136\/ard.56.1.27_bib20","first-page":"393","article-title":"Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis.","volume":"37","author":"Ritchie","year":"1968","journal-title":"Q J Med"},{"key":"10.1136\/ard.56.1.27_bib21","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/art.1780300603","article-title":"Articular indices of joint inflammation in rheumatoid arthritis.","volume":"30","author":"Thompson","year":"1987","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.56.1.27_bib22","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/art.1780301203","article-title":"Circulating hyaluronic acid levels vary with physical activity in healthy subjects and in rheumatoid arthritis patients: relationship to synovitis mass and morning stiffness.","volume":"30","author":"Engstr\u00f6m-Laurent","year":"1987","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.56.1.27_bib23","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/rheumatology\/34.4.321","article-title":"Interleukin-6 (IL-6) induces the proliferation of synovial fibroblastic cells in the prescence of soluble IL-6 receptor.","volume":"34","author":"Mihara","year":"1995","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.56.1.27_bib24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/ard.53.1.39","article-title":"Synovial tissue macrophages and joint erosion in rheumatoid arthrits.","volume":"53","author":"Yanni","year":"1994","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.56.1.27_bib25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1136\/ard.54.1.33","article-title":"Interleukin-6 in relation to other proinflammatory cytokines, chemotactic activity and neutrophil activation in rheumatoid synovial fluid.","volume":"54","author":"van Leeuwen","year":"1995","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.56.1.27_bib26","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/art.1780360807","article-title":"Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor alpha and interleukin-6 levels in rheumatoid arthritis.","volume":"36","author":"Barrera","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.56.1.27_bib27","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1093\/rheumatology\/31.11.725","article-title":"Cytokine inter-relationships and their association with disease activity in arthritis.","volume":"31","author":"Holt","year":"1992","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.56.1.27_bib28","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1136\/ard.52.3.232","article-title":"Serum IL-6 levels in rheumatoid arthritis:correlations with clinical and laboratory indices of disease activity.","volume":"52","author":"Madhok","year":"1993","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.56.1.27_bib29","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/art.1780340912","article-title":"Correlation of serum interleukin-6 levels with joint involvment and trombocytosis in systemic juvenile rheumatoid arthritis.","volume":"34","author":"De Benedetti","year":"1991","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.56.1.27_bib30","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2165\/00003088-197904020-00004","article-title":"Clinical pharmacokinetics of prednisone and prednisolone.","volume":"4","author":"Pickup","year":"1978","journal-title":"Clin Pharmacokinet"},{"key":"10.1136\/ard.56.1.27_bib31","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/ajcp\/69.1.48","article-title":"Evaluation of biologic sources of variation of leukocyte counts and other hematologic quantities using very precise automated analyzers.","volume":"69","author":"Statland","year":"1978","journal-title":"Am J Pathol"},{"key":"10.1136\/ard.56.1.27_bib32","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1365-2141.1983.tb02843.x","article-title":"Steroid modulation of naturally occurring diurnal variation in circulating pluripotential haematopoietic cells.","volume":"55","author":"Lasky","year":"1983","journal-title":"Br J Haematol"},{"key":"10.1136\/ard.56.1.27_bib33","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1056\/NEJM199507203330302","article-title":"The effect of glucocorticoids on joint destruction in rheumatoid arthritis.","volume":"333","author":"Kirwan","year":"1995","journal-title":"N Eng J Med"},{"key":"10.1136\/ard.56.1.27_bib34","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/0002-9343(93)90277-V","article-title":"Recovery of the hypothalamic-pituitary-adrenal (HPA) axis in patients with rheumatic diseases receiving low-dose prednisone.","volume":"95","author":"La Rochelle","year":"1993","journal-title":"Am J Med"},{"key":"10.1136\/ard.56.1.27_bib35","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0221-8747(84)90064-X","article-title":"Production of osteocalcin by human bone cells in vitro. Effects of 1.25(OH)2D3, 24,25(OH)2D3, parathyroid hormone and glucocorticoids.","volume":"5","author":"Beresford","year":"1984","journal-title":"Metab Bone Dis Relat Res"},{"key":"10.1136\/ard.56.1.27_bib36","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1210\/jcem-62-2-379","article-title":"Low serum osteocalcin levels in glucocorticoid-treated asthmatics.","volume":"62","author":"Reid","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1136\/ard.56.1.27_bib37","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0002-9343(94)90131-7","article-title":"Low dose long-term corticoid therapy in rheumatoid arthritis: an analysis of serious adverse events.","volume":"96","author":"Saag","year":"1994","journal-title":"Am J Med"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724501182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724501182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.56.1.27","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T09:45:55Z","timestamp":1737539155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724501182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1997,1]]}},"alternative-id":["S0003496724501182"],"URL":"https:\/\/doi.org\/10.1136\/ard.56.1.27","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[1997,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The timing of glucocorticoid administration in rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.56.1.27","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1997 Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}